Scholarly Index
Anthony Gonçalvès
Institut Paoli-Calmettes; 19,001 total citations; 597 total publications; best world rank #91
Institut Paoli-Calmettes
19,001Total citations
597Total publications
62H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Treatment and Pharmacology | Lifetime | 503 | FR 35 | 98.59 |
| Advanced Breast Cancer Therapies | Lifetime | 172 | FR 10 | 98.53 |
| HER2/EGFR in Cancer Research | Lifetime | 372 | FR 14 | 98.39 |
| PARP inhibition in cancer therapy | Lifetime | 231 | FR 9 | 96.96 |
| Breast Cancer Treatment Studies | Lifetime | 906 | FR 44 | 97.53 |
| BRCA gene mutations in cancer | Lifetime | 839 | FR 23 | 95.24 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 483 | FR 27 | 98.11 |
| Advanced Breast Cancer Therapies | 2021-2025 | 91 | FR 9 | 98.49 |
| Breast Cancer Treatment Studies | 2021-2025 | 206 | FR 11 | 97.61 |
| HER2/EGFR in Cancer Research | 2021-2025 | 187 | FR 13 | 97.12 |
| Cancer Genomics and Diagnostics | 2021-2025 | 800 | FR 30 | 95.28 |
| Cancer Treatment and Pharmacology | 2021-2025 | 221 | FR 19 | 95.62 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 230 | FR 5 | 81.05 |
| Cancer-related Molecular Pathways | 2021-2025 | 485 | FR 10 | 81.25 |
| Brain Metastases and Treatment | 2021-2025 | 991 | FR 33 | 81.02 |